The recent investigation at Sassoon Hospital in Pune has shed light on a concerning issue involving potentially fake medicines supplied by Vishal Enterprises. The hospital’s Dean, Dr. Eknath Pawar, has taken decisive actions to address the situation and ensure patient safety.
Here are some key points to know about the ongoing investigation:
1. Medicines Under Investigation: The FDA has seized and sent samples of five types of medicines to a laboratory for testing. These include pain relievers, epilepsy medications, corticosteroids, and gynecological treatments.
2. Previous Incidents: Vishal Enterprises has been linked to multiple cases of distributing fake medicines in government hospitals across Maharashtra. This has raised serious concerns about the reliability of medicine supply chains.
3. Preventive Measures: Sassoon Hospital has sealed the suspect stock of medicines supplied by Vishal Enterprises, suspended payments to the vendor, and stopped distribution of the stock. These measures are precautionary and aimed at avoiding any potential risks to patients.
4. FDA’s Assurance: The FDA Pune Assistant Commissioner has assured that stringent actions will be taken against any parties found guilty. Precautionary measures are in place to protect patients, and the test results will guide further steps to address the situation.
The investigation at Sassoon Hospital highlights the importance of ensuring the safety and authenticity of medicines supplied to healthcare facilities. Stay tuned for updates on this developing story.
Thanks For Reading Report of Punepress.com